Kangmei Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	26,551	32,441	25,787	30,501	42,839	13,330
Market Cap Growth	-13.34%	25.81%	-15.46%	-28.80%	221.38%	-28.15%
Enterprise Value	25,527	31,918	24,904	28,797	76,028	47,878
Last Close Price	1.92	2.34	1.86	2.20	3.09	2.68
PE Ratio	1595.60	3783.85	251.53	-	5.41	-
Forward PE	-	2.56	2.56	2.56	2.56	2.56
PS Ratio	5.03	6.25	5.29	7.30	10.32	2.46
PB Ratio	3.68	4.50	3.64	4.37	4.30	-1.28
P/TBV Ratio	3.97	4.87	4.00	4.83	4.64	-
P/FCF Ratio	-	-	-	-	1006.12	18.27
P/OCF Ratio	443.25	-	-	-	199.99	12.92
PEG Ratio	-	0.53	0.53	0.53	0.53	0.53
EV/Sales Ratio	4.84	6.15	5.11	6.89	18.31	8.85
EV/EBITDA Ratio	-	-	52.89	-	-	-
EV/EBIT Ratio	-	-	138.67	-	-	-
EV/FCF Ratio	-659.38	-	-	-	1785.59	65.62
Debt / Equity Ratio	0.02	0.02	0.04	0.04	0.02	-2.09
Debt / EBITDA Ratio	2.26	-	0.49	-	-	-
Debt / FCF Ratio	-	-	-	-	4.82	29.78
Asset Turnover	0.38	0.37	0.33	0.27	0.17	0.11
Inventory Turnover	1.65	1.76	1.54	1.26	0.91	1.57
Quick Ratio	0.75	0.74	0.69	0.82	1.00	0.54
Current Ratio	1.21	1.17	1.12	1.36	1.68	0.80
Return on Equity (ROE)	0.27%	0.17%	1.47%	-31.78%	-	-607.26%
Return on Assets (ROA)	-1.23%	-1.84%	0.76%	-4.17%	-7.71%	-34.21%
Return on Invested Capital (ROIC)	-1.80%	-2.28%	2.80%	-15.42%	-31.95%	-83.93%
Return on Capital Employed (ROCE)	-3.50%	-5.20%	2.20%	-10.70%	-27.40%	-266.80%
Earnings Yield	0.06%	0.03%	0.40%	-8.81%	18.48%	-233.19%
FCF Yield	-0.15%	-1.51%	-1.62%	-2.62%	0.10%	5.47%
Payout Ratio	4.51%	8.75%	-	-	0.17%	-
Buyback Yield / Dilution	0.25%	-39.38%	27.54%	-1.85%	-0.55%	-179.83%
Total Shareholder Return	0.25%	-39.38%	27.54%	-1.85%	-0.55%	-179.83%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.